With the wide-spread pandemic COVID-19 all over the news, healthcare providers are figuring out ways to find a cure to the disease. Adaptive Biotechnologies Corp. and Microsoft Corp. announced that they will utilize their partnership together to work towards an advanced solution that caters for population-wide adaptive immune responses. This is done to promote the treatment and prevention of the disease and on-going research on the biology of the virus.
In a virtual clinic, managed by Covance, immune response data is generated by collecting de-identified blood samples from people diagnosed with COVID-19 via LabCorp-enabled mobile phlebotomy service. Both the companies are seeking additional participation from other research labs and groups to further enhance the research and carry out studies on an extended data set.
Ultimately, the solution to COVID-19 problems is not likely to come from one person or group. Several labs and research groups powered by companies like Microsoft have to work together to find the solution to COVID-19 testing needs.
